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RESE ARCH ARTICLE

Retinoid isomerase inhibitors impair but do not block
mammalian cone photoreceptor function
Philip D. Kiser1,2, Jianye Zhang2, Aditya Sharma3, Juan M. Angueyra4, Alexander V. Kolesnikov3, Mohsen Badiee5, Gregory P. Tochtrop5,
Junzo Kinoshita6, Neal S. Peachey1,6,7, Wei Li4, Vladimir J. Kefalov3, and Krzysztof Palczewski2

Visual function in vertebrates critically depends on the continuous regeneration of visual pigments in rod and cone
photoreceptors. RPE65 is a well-established retinoid isomerase in the pigment epithelium that regenerates rhodopsin
during the rod visual cycle; however, its contribution to the regeneration of cone pigments remains obscure. In this study,
we use potent and selective RPE65 inhibitors in rod- and cone-dominant animal models to discern the role of this enzyme
in cone-mediated vision. We confirm that retinylamine and emixustat-family compounds selectively inhibit RPE65 over
DES1, the putative retinoid isomerase of the intraretinal visual cycle. In vivo and ex vivo electroretinography experiments
in Gnat1−/− mice demonstrate that acute administration of RPE65 inhibitors after a bleach suppresses the late, slow
phase of cone dark adaptation without affecting the initial rapid portion, which reflects intraretinal visual cycle function.
Acute administration of these compounds does not affect the light sensitivity of cone photoreceptors in mice during
extended exposure to background light, but does slow all phases of subsequent dark recovery. We also show that cone
function is only partially suppressed in cone-dominant ground squirrels and wild-type mice by multiday administration
of an RPE65 inhibitor despite profound blockade of RPE65 activity. Complementary experiments in these animal models
using the DES1 inhibitor fenretinide show more modest effects on cone recovery. Collectively, these studies demonstrate
a role for continuous RPE65 activity in mammalian cone pigment regeneration and provide further evidence for RPE65independent regeneration mechanisms.

Introduction

Light perception by the vertebrate eye begins with a cis-to-trans
photoisomerization of the retinylidene chromophore of photoreceptor cell visual pigments. This geometric change converts the
opsin protein component of these pigments to an active signaling state, which is capable of initiating the phototransduction
cascade with consequent changes in second messenger levels
and plasma membrane potentials. In this way, a light stimulus
is converted to an electrical signal, which is propagated to the
brain for interpretation of the visual world. Photoreceptor signaling is sustained by a regeneration process that carries out the
light-independent, endergonic conversion of trans-retinoid back
to an 11-cis configuration, a pathway known as the retinoid or
visual cycle (Saari, 2012; Kiser et al., 2014). The classic version
of this pathway involves chemical transformations occurring
in the retinal pigment epithelium (RPE) that are critical for the
regeneration of rod visual pigments (Fig. 1; Kuhne, 1878). In this

pathway, all-trans-retinaldehyde released from bleached visual
pigments is converted to vitamin A, which is trapped in the RPE
through the action of an esterifying enzyme called lecithin-retinol acyltransferase (LRAT; Saari and Bredberg, 1989). These retinyl esters serve as substrates for the membrane-bound enzyme
RPE65 (RPE-specific 65-kD protein), which cleaves and isomerizes them to form 11-cis-retinol (Redmond et al., 1998). This
cis-retinoid is further oxidized and then shuttled back to photoreceptor outer segments, where it combines with free opsins to
form ground state pigments poised for subsequent light activation (Palczewski, 2006).
A conundrum exists regarding the role of RPE65 in cone
visual pigment regeneration. On the one hand, the severely
attenuated cone electroretinography (ERG) responses in Rpe65
knockout mice (Redmond et al., 1998; Seeliger et al., 2001; Maeda
et al., 2009) as well as humans (Jacobson et al., 2007, 2009) and
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Figure 1. Mechanisms for visual chromophore production in the retina
relevant to cone pigment regeneration. Cone-mediated vision is initiated by
photoisomerization of 11-cis-retinaldehyde bound to cone visual pigments, a
process that leads to pigment activation and initiation of phototransduction.
Photoisomerization leads to the release of all-trans-retinaldehyde from the
visual pigment, which must be regenerated to allow for sustained visual function. Two enzymatic systems are thought to contribute to 11-cis-retinaldehyde production for the regeneration of cone pigments. The classical RPE65dependent visual cycle pathway involves enzymes and retinoid-binding proteins located in photoreceptor outer segments and the RPE. This pathway
is also critically involved in rod pigment regeneration. The RPE can store
11-cis-retinoids either in the form of 11-cis-retinaldehyde or 11-cis-retinol
complexed with cellular retinaldehyde-binding proteins or, in some species,
as 11-cis-retinyl esters. A second cone-specific enzymatic pathway, which
is believed to be RPE65 independent and mechanistically distinct from the
classical visual cycle, may involve enzymes and binding protein components
located in cones and Müller cells. This pathway could generate the 11-cis-retinoids that are present in Müller glia, but such compounds could also originate in the RPE and be transferred through the retina to the Müller cells.
Müller cells can store 11-cis-retinoids by the same mechanisms as used by
RPE, but the extent of 11-cis-retinyl ester formation is species dependent,
typically being higher in diurnal animals. Selective regeneration of cone visual
pigments relies on the unique ability of cones to use 11-cis-retinol delivered
by Müller cells to form the necessary visual chromophore 11-cis-retinaldehyde. 11-cis-retinaldehyde also can be generated in situ in a light-dependent
fashion via photoisomerization of all-trans-retinaldehyde-phosphatidylethanolamine Schiff base adducts. In this figure, solid lines indicate established
pathways, whereas dashed lines indicate processes that are either hypothetical or not yet fully characterized. 11cRAL, 11-cis-retinaldehyde; 11cROL, 11-cisretinol; atRAL, all-trans-retinaldehyde; atRE, all-trans-retinyl ester; atROL,
all-trans-retinol; hν, a photon; PE, phosphatidylethanolamine.

dogs (Acland et al., 2005) with loss of function RPE65 mutations, together with the apparent lack of cone pigment formation in Nrl−/−Rpe65−/− mice (Wenzel et al., 2007; Feathers et al.,
2008), suggest that RPE65 is an essential component of the cone
pigment regeneration pathway, as is the enrichment of RPE65
expression and function in the cone-rich foveal region of the
Kiser et al.
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primate retina (Jacobson et al., 2007). Data showing enhanced
isomerase activity for RPE65 from the cone-dominant chicken
compared with orthologues from rod-dominant rodent species
also suggest a mechanism whereby classical visual cycle activity
can be tuned to match the high visual chromophore demands of
cone photoreceptors (Moiseyev et al., 2008).
On the other hand, there are several lines of biochemical and
electrophysiological evidence to suggest that the neurosensory
retina possesses alternative visual cycle machinery devoted to
cone pigment regeneration, indicating that there are RPE65-independent mechanisms for visual chromophore production
(Fig. 1; Mata et al., 2002; Muniz et al., 2009; Wang et al., 2009).
This alternative route of visual chromophore delivery is critically
dependent on Müller glia (Jones et al., 1989; Das et al., 1992; Mata
et al., 2002; Wang and Kefalov, 2009, 2011; Saari, 2012), and candidate enzymes of the mammalian pathway have recently been
identified, including the putative isomerase sphingolipid delta(4)-desaturase 1 (DES1; Kaylor et al., 2013). Additional enzymes
and potentially alternative enzymatic activities involved in
cis-retinoid formation have also been identified in Müller cells
of chicken (Muniz et al., 2009) and zebrafish (Takahashi et al.,
2011) retina. More recent work has shown that 11-cis-retinaldehyde can also be generated nonenzymatically in situ within
photoreceptor outer segments through the action of blue light
on all-trans-retinaldehyde-phosphatidylethanolamine adducts
(Kaylor et al., 2017). Notably, the emergence of ancestral cone pigments during chordate evolution (Lamb, 2013) is thought to have
preceded the development of RPE65 and the classical visual cycle
in vertebrates by several million years (Albalat, 2012; Poliakov et
al., 2012b), indicating the existence of alternative chromophore
regeneration pathway(s) that could be retained in extant species
(Kusakabe et al., 2001). However, no direct genetic evidence yet
demonstrates the involvement of alternative enzymes in cone
pigment regeneration, and the existence of an RPE65-independent, cone-specific regeneration pathway remains controversial.
The rapid degeneration of cone photoreceptors that occurs in
response to genetic perturbations of the RPE65 gene complicates
the analysis of cone photoreceptor dependence on this enzyme
(Cideciyan, 2010). Use of pharmacological agents to acutely block
RPE65 function without direct effects on cone photoreceptor
health offers an experimental strategy to overcome this limitation. Analysis of putative RPE65 isomerization intermediates has
helped to identify retinylamine (Ret-NH2) as a transition state
analogue inhibitor of RPE65 (Golczak et al., 2005b). Subsequent
studies led to the identification of a related but more potent
inhibitor, emixustat (Bavik et al., 2015), which was developed as a
visual cycle modulator for the treatment of dry, age-related macular degeneration (Kubota et al., 2012). The structure of this molecule in complex with RPE65 has provided a clear understanding
of its mode of action as a competitive inhibitor of retinyl ester
binding (Kiser et al., 2015). Likewise, the retinoic acid derivative
fenretinide has been identified as a competitive inhibitor of DES1
activity (Rahmaniyan et al., 2011; Kaylor et al., 2013), although
this molecule is known to interact with other molecular targets
(Berni and Formelli, 1992; Dew et al., 1993; Poliakov et al., 2012a).
Pharmacological approaches have previously been used to study
isomerase activity in vitro (Gollapalli and Rando, 2003; Golczak
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et al., 2005b, 2008; Muniz et al., 2009; Poliakov et al., 2011) as
well as in mice (Golczak et al., 2005b; Mandal et al., 2011) and
zebrafish (Schonthaler et al., 2007; Babino et al., 2015). However, the selectivity and potency of agents used in these studies
were, in many cases, either unknown or not ideal. Emixustat and
related derivatives such as MB-001 (Kiser et al., 2015), however,
have well-validated modes of RPE65 inhibition with good in vivo
activity and are therefore important new tools for studying the
role of RPE65 in rod and cone visual pigment regeneration.
In this study, we determined the inhibitory specificity of
Ret-NH2/emixustat-family compounds toward RPE65 and then
investigated how selective and acute suppression of the RPEbased visual cycle affects cone function and dark adaptation in
mice and ground squirrels possessing rod- and cone-dominant
retinas, respectively. We also investigated the effects of fenretinide treatment on cone function. These experiments allowed
us to determine the relative importance of the RPE65-dependent
visual cycle in acutely supplying visual chromophore to cones
and supporting cone-mediated daytime vision without inducing
photoreceptor degeneration.

Materials and methods

Chemicals and synthesis
Ret-NH2 (Golczak et al., 2005b), QEA-B-001-NH2 (Zhang et al.,
2015b), emixustat, and MB-001 (Kiser et al., 2015) were synthesized according to previously described procedures. Fenretinide
was purchased from Sigma-Aldrich or Toronto Research Chemicals, and the chemical identity was confirmed by optical spectroscopy. Standard laboratory chemicals were purchased from
Sigma-Aldrich or USB and were of the highest available purity.
Retinoid isomerase activity assays
RPE65 retinoid isomerase activity was assayed as previously
described (Stecher et al., 1999; McBee et al., 2000). Assays with
ground squirrel RPE samples were performed using whole cell
lysates as opposed to isolated microsomes because of the limited
amount of material available.
RPE65 immunoblotting
Protein samples containing RPE65 were separated by SDS-PAGE
on a 10% Tris-glycine polyacrylamide gel and then transferred
to a 0.45-µm pore size polyvinylidene difluoride membrane.
Phosphate-buffered saline containing 0.05% Tween 20 (Thermo
Fisher Scientific) and 5% nonfat powdered milk was used as the
blocking and incubation buffer. An in-house–generated RPE65
antibody (Golczak et al., 2010) at a 1:1,000 dilution was used for
the primary incubation, which was subsequently detected with
a horseradish peroxidase–conjugated anti–mouse IgG secondary
antibody (Promega) and chemiluminescence reagent (Thermo
Fisher Scientific).
Animal handling
Mice were housed in the animal facilities at the Case Western
Reserve University School of Medicine, where they received a
standard chow diet (LabDiet 5053) and were maintained under
a 12-h light (∼300 lux) and 12-h dark cycle; at the Washington
Kiser et al.
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University School of Medicine, where they received a standard
chow diet (LabDiet 5053) and were maintained under a 12-h
light (∼20 lux) and 12-h dark cycle; or at the Cole Eye Institute
animal facility, where they received LabDiet 2918 and were
maintained under a 14-h light (∼100 lux) and 10-h dark cycle.
13-lined ground squirrels (Ictidomys tridecemlineatus) were
housed individually at the National Institutes of Health Veterinary Research and Resources Section, where they received a Cat
Chow Complete (Nestlé Purina) diet and were kept in a 12-h light
and 12-h dark cycle.
All animal procedures and experiments were approved by the
Institutional Animal Care and Use Committees of Case Western
Reserve University, the National Eye Institute, Washington University, or the Cleveland Clinic; conformed to the recommendations of the American Veterinary Medical Association Panel on
Euthanasia; and were conducted in accordance with the Association for Research in Vision and Ophthalmology Statement for the
Use of Animals in Ophthalmic and Visual Research.
Liver microsome isolation
Liver microsomes from Lrat−/− mice on a C57BL/6J genetic background were used as the enzyme source for the DES1 activity
assays to eliminate potential LRAT-dependent acylation of test
compounds (Batten et al., 2004; Golczak et al., 2005a; Zhang et
al., 2015b). Four 8-wk-old mice were euthanized by CO2 asphyxiation and cervical dislocation, and their livers (4.6 g in total) were
removed by dissection, washed in ice-cold phosphate-buffered
saline, flash frozen in liquid nitrogen, and stored at −80°C. Liver
microsomes were isolated by differential centrifugation as previously described (Schulze et al., 2000). The microsomes then
were suspended in 100 mM sodium phosphate, pH 7.4, to a final
protein concentration of 15 mg/ml as determined by the Bradford
assay with BSA used as the standard. Microsome preparations
were flash frozen in liquid nitrogen and stored at −80°C.
DES1 activity assays
Based on the finding that the retinol isomerase activity of DES1
is competitive with its dihydroceramide desaturase activity
(Kaylor et al., 2013), the influence of RPE65 inhibitors on DES1
catalytic function was assessed by measuring DES1 dihydroceramide activity in the presence of these compounds with a radioactivity-based assay in which 3H is released from 4,5-3H-dihydro
ceramide in the form of tritiated water as a result of DES1 catalytic
activity. This assay used mouse liver microsomes isolated as
described in the preceding section along with a substrate, N-octanoyl-dihydroceramide (C8-dihydroceramide), which has been
previously shown to compete with retinol for binding to the DES1
active site (Fig. S1 A; Schulze et al., 2000; Kaylor et al., 2013). The
dihydroceramide desaturase activity from this source was linear
over the assay time course and approximately proportional to the
enzyme concentration (Fig. S1 B) and also exhibited steady-state
kinetic parameters similar to those previously reported for rat
liver microsomes (Fig. S1 C; Rahmaniyan et al., 2011). Reactions
were performed in 20 mM sodium phosphate, pH 8, containing 50 mM NaCl, 50 mM sucrose, 2 mM reduced nicotinamide
adenine dinucleotide (NADH), and 120 µg microsomal protein
in a total volume of 500 µl. C8-dihydroceramide (Matreya),
Journal of General Physiology
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solubilized in 100 mM sodium phosphate, pH 7.4, containing
179 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS; Anatrace), was used as a substrate for the
reaction. 1 µl ethanolic solution of 4,5-3H-C8-dihydroceramide (1
µCi/µl; American Radiolabeled Chemicals) was added to 22.2 µl of
solubilization buffer, and the mixture was vortexed for 30 s. 1 µl
of the diluted radiolabeled substrate (0.043 µCi, ∼150,000 dpm)
was used per reaction. The final concentration of CHAPS in the
reaction mixtures was fixed at 1.59 mM. For inhibitor studies,
the test compounds were delivered into the reaction system in
DMSO, and the sample was mixed by brief vortexing. The final
DMSO concentration in the assay system was fixed at 0.2% vol/
vol, a level that did not affect DES1 activity. Reaction mixtures
were preincubated for 10 min at 37°C, and reactions were then
initiated by addition of substrate followed by brief vortexing.
Reactions were performed at 37°C with 550 rpm shaking for
20 min in 1.5-ml tubes. Reactions performed in the absence of
NADH or with heat-treated microsomes were used to determine
the background level of the assay. Reactions were terminated
with 100 µl of 72% trichloroacetic acid followed by vortexing.
The resulting precipitates were sedimented by centrifugation
at 16,100 g for 4 min. Supernatants were removed and added to
1 ml of 0.4 M Na2HPO4 to partially deacidify the solution. The
resulting mixtures were then applied to a 500-mg, 3-ml Bond
Elut C18 column (Agilent) preconditioned with 2 ml of 100%
MeOH followed by equilibration with 2 ml Millipore water.
Liquid was drawn through the column with a vacuum manifold operating at ≤5 inches of Hg. 2 ml Millipore water was then
drawn through the column to capture residual aqueous radioactivity. The entire flow-through volume was added to 10 ml of
Ultima Gold XR scintillation cocktail (Perkin-Elmer) and mixed
by shaking. Scintillation recordings were made with a Beckman
LS6500 instrument.
In vivo ERG of Gnat1−/− mice
3-mo-old Gnat1−/− mice on a BALB/c background (Leu450 variant of RPE65) were dark adapted overnight and then anesthetized with an intraperitoneal (IP) injection of a ketamine (100
mg/kg) and xylazine (20 mg/kg) mixture. Pupils were dilated
with a drop of 1% atropine sulfate. The mouse body temperature was maintained at 37°C with a heating pad. ERG responses
were recorded from both eyes by contact electrodes connected
to the cornea by a drop of Gonak solution. Full-field ERGs were
performed with a UTAS BigShot apparatus (LKC Technologies)
using Ganzfeld-derived test flashes of calibrated green 530-nm
light-emitting diode (LED) light ranging from 0.24 to 7.45 cd∙s/
m2. Cone b-wave flash sensitivity (Sf ) was first calculated in the
dark as follows:
	S f  = R / (Rm
  ax  ⋅ I),
where R is the cone b-wave dim flash response amplitude, Rmax
is the maximal response amplitude for that retina obtained with
the brightest white light stimulus of the Xenon Flash tube (700
cd∙s/m2), and I is the flash strength. Then, >90% of the M-cone
pigment was bleached by a 30-s exposure to 520-nm LED light
focused at the surface of the cornea. The bleaching fraction was
estimated with the following equation:
Kiser et al.
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F = 1 − e  −I⋅P⋅t,
where F is the fraction of bleached pigment, t is the duration of
the exposure to light (in seconds), I is the bleaching light intensity
of unattenuated 520-nm LED light (∼1.3 × 108 photons µm−2s−1),
and P is the photosensitivity of the mouse cone at the wavelength
of peak absorbance (7.5 × 10−9 µm2), adopted from Nikonov et al.
(2006). After the bleach, recovery of cone b-wave Sf was followed
in the dark for up to 1 h. Mice were reanesthetized once (at 20 min
after bleach) with a smaller dose of ketamine (approximately half
the initial dose), and a 1:1 mixture of phosphate-buffered saline
and Gonak solutions was gently applied to the eyes to protect them
from drying and to maintain electrode contacts.
To test cone function under extended photopic conditions,
white-background Ganzfeld illumination (300 cd/m2) was
applied to dark-adapted mice continuously for 30 min, and the
cone b-wave Sf change was monitored during this period. After
the exposure, recovery of cone b-wave Sf was monitored in the
dark for up to 1 h, and anesthesia was reapplied every 30 min.
Ret-NH2 was dissolved before each experiment in DMSO to
5 µg/µl, and 50 µl of this solution was administered by IP injection in the dark, followed by a period of 22–26 h of dark adaptation before recordings. The other compounds were delivered
similarly in 50 µl DMSO. Their final concentrations were 4 µg/
µl emixustat, 4 µg/µl MB-001, or 40 µg/µl QEA-B-001-NH2. Control animals were injected with 50 µl DMSO and processed in the
same way as drug-treated mice.
Ex vivo ERG recordings from isolated Gnat1−/− mouse retinas
3-mo-old Gnat1−/− mice were dark adapted overnight and sacrificed. A whole retina was removed from each mouse eyecup
under infrared illumination and stored in oxygenated aqueous L15 solution (13.6 mg/ml, pH 7.4; Sigma-Aldrich) containing 0.1% BSA at room temperature. The retina was mounted
on filter paper with the photoreceptor side up and placed in a
perfusion chamber between two electrodes connected to a differential amplifier. The preparation was perfused with Locke’s
solution containing 112.5 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2,
1.2 mM CaCl2, 10 mM HEPES, pH 7.4, 20 mM NaHCO3, 3 mM
sodium succinate, 0.5 mM sodium glutamate, 0.02 mM EDTA,
and 10 mM glucose. This solution was supplemented with 2 mM
l-glutamate and 10 µM dl-2-amino-4-phosphonobutyric acid to
block postsynaptic components of the photoresponse (Sillman
et al., 1969) and with 20 µM BaCl2 to suppress the slow glial
PIII component (Nymark et al., 2005). The perfusion solution
was continuously bubbled with a 95% O2/5% CO2 mixture and
heated to 36–37°C.
Light stimulation was applied in 20-ms test flashes of calibrated 505-nm LED light. The light intensity was controlled by a
computer in 0.5 log unit steps. To monitor the recovery of cone
a-wave flash sensitivity (Sf, defined as for the b-wave above) after
the bleach, >90% of M-cone visual pigment was bleached with a
3-s exposure to 505-nm light. Photoresponses were amplified by
a differential amplifier (DP-311; Warner Instruments), low-pass
filtered at 30 Hz (eight-pole Bessel), digitized at 1 kHz, and stored
on a computer. Data were analyzed with Clampfit 10.4 (Molecular
Devices) and Origin 8.5 (OriginLab) software.
Journal of General Physiology
https://doi.org/10.1085/jgp.201711815

574

Ret-NH2 and DMSO were administered to each dark-adapted
mouse by IP injection as described above, followed by a further
period of 15–17 h of dark adaptation before physiological recordings. Fenretinide was dissolved in DMSO and acutely added to the
isolated, dark-adapted retina, which was flat mounted on filter
paper with the photoreceptor side up and placed into 2 ml L15
solution containing 1% BSA (final concentrations of the drug were
100 µM or 650 µM, and that of DMSO was 1.3%). After preincubation for 1 h at room temperature, the retina was exposed to moderate 520-nm light for 2 min to bleach the bulk of cone pigment, and
trans-retinal ERG recordings were performed after another hour
in darkness. Control experiments were performed in an identical
way but with DMSO only. Some retinas were treated with fenretinide or DMSO for 1 h but not bleached before recordings.
In vivo ERGs in wild-type mice
C57BL/6J mice aged 2 or 7 mo were anesthetized with ketamine
(80 mg/kg) and xylazine (16 mg/kg). Mydriatic eye drops (1%
tropicamide–2.5% phenylephrine–1% cyclopentolate or 1% tropicamide alone) were used to dilate the pupil. ERGs were obtained
using a stainless steel active electrode that contacted the corneal
surface through a layer of 1% carboxymethylcellulose or normal
saline. Needle electrodes placed in the cheek and tail provided
reference and ground leads, respectively. Strobe stimuli were
presented in a Ganzfeld (LKC Technologies), either in darkness or
under photopic conditions where stimulus flashes were superimposed on a steady adapting field (20 cd/m2) after at least 5 min of
light adaptation. Responses were amplified, averaged, and stored
using an LKC Technologies UTAS E-3000 signal averaging system. Under dark-adapted conditions, stimulus strength ranged
from −3.6 to 2.1 log cd·s/m2. Across this range, the interstimulus interval increased from 4 to 65 s with increasing flash luminance, whereas the number of averaged consecutive responses
decreased over the same stimulus range from 20 at the lowest
flash luminance to a single response at the highest strength stimulus. Under light-adapted conditions, stimulus strength ranged
from −0.4 to 1.9 log cd·s/m2, and flashes were presented at 2 Hz.
For each light-adapted stimulus condition, up to 50 consecutive
responses were averaged.
Baseline light-adapted ERGs were recorded from each mouse.
Mice were injected IP in the morning with 50 µl of vehicle (10%
DMSO in normal saline) or MB-001 (160 µg/mouse/day) for three
successive days and kept under normal cyclic lighting conditions
(14 h light/10 h dark). Both male and female mice were used. The
morning after the final injection, mydriatic eye drops were used
to dilate the pupils. Mice were placed in darkness after one of two
light exposures. Bleach mice were exposed to a 10-min × 10,000lux bleach, whereas no bleach mice were not. After a 6-h dark
adaptation, mice were anesthetized as described above, and a
series of dark- and light-adapted ERGs were recorded.
For fenretinide experiments, mice were given either 6 mg fenretinide (∼267 mg/kg) or vehicle (50% DMSO and 25% ethanol
in water) by IP injection for three consecutive days. On the third
day, 1 h after the final dose, the animals were given mydriatic
eye drops and then were subjected to a 10-min × 10,000-lux photobleach. The animals were then allowed to dark adapt for 6 h
before ERG recordings.
Kiser et al.
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To test the impact of MB-001 treatment on fully dark-adapted
rod responses without a prior photobleach or other light exposure during the period of drug exposure, MB-001 at a dose of 8
mg/kg was given to 2-mo-old C57BL/6J mice for two consecutive
days via IP injection. These mice were housed in darkness for
24 h before drug administration, and the drug was administered
under dim red light. After the recording of dark-adapted ERGs
2 h after the second dose using the protocol described above, the
animals were subjected to a 10-min × 10,000-lux photobleach
under anesthesia and then allowed to dark adapt for 22 h. After
this period, scotopic ERGs were remeasured. For MB-001–treated
mice, dark-adapted ERGs were also measured again after a 2-wk
drug washout period.
In vivo ERGs in squirrels
Healthy 13-lined ground squirrels (I. tridicemlineatus, 3–6
mo old, during the summer season) of both sexes were used
for ERG recordings. Before ERG recording, the animals were
anesthetized using 3–4% isofluorane suspended in pure oxygen, and their pupils were dilated using ophthalmic 1% tropicamide and 2.5% phenylephrine, with 0.5% proparacaine used
as a local anesthetic. Body temperature was maintained at 37°C
with a warm bed, and the heart rate was monitored continuously. ERG signals were measured differentially using gold
electrodes coated with hydroxypropyl-methylcellulose that
were pressed into the cornea of both eyes, and a subdermal
scalp tungsten needle was the reference electrode. The Espion
Color-Dome system (Diagnosys LLC) was used for data acquisition and stimulation. The data were sampled at a rate of 1,000
Hz and low-pass filtered at 200 Hz. The built-in xenon lamp
was used for stimulation with flashes of <2 ms in duration
and spanning 0.1–4,000 cd·s/m2 in intensity. In preliminary
experiments with normal squirrels, exposure to a bright and
broadband LED source (Migthex White LED 5 500K at maximal intensity, focused on one eye at a distance of 10 cm and for
a 10-min period) successfully suppressed the response (>90%)
to a midintensity flash (100 cd·s/m2), with near-complete
recovery of responses in the following 10 min. This treatment
was adopted as our bleaching protocol. The recovery of ERG
sensitivity was monitored after the photobleach by delivering
midsaturating flashes (100 cd·s/m2 except for one high-dose
MB-001–treated animal in which 300 cd·s/m2 was used) every
1.5 s, with periodic gaps required to save data and restart the
stimulation protocol.
After recording baseline ERGs, the animals were injected with
MB-001 or vehicle using two different treatment protocols. In
the first, MB-001 at a dose of 8 mg/kg/day or the vehicle solution (10% vol/vol DMSO in 0.9% saline) was injected IP for three
consecutive days in four squirrels. During this time, the animals
were kept under normal cyclical lighting conditions. After the 3
d of treatment, ERGs were recorded again. After a 6-wk washout period, the treatments were crossed over in the same four
subjects to perform a paired analysis, repeating the same procedures but opposite treatments. After the last recording, the
squirrels were sacrificed by decapitation after deep anesthesia
with isofluorane, and their eyes were collected and immediately
immersed into liquid nitrogen. The eyes were stored at −80°C
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until quantification of MB-001 levels. In the second treatment
protocol, either MB-001 at doses of 8 mg/kg/day or 80 mg/kg/
day or vehicle (50% vol/vol DMSO and 25% vol/vol EtOH in water)
was injected IP for three consecutive days. A fenretinide treatment group (166 mg/kg/day delivered IP in the same vehicle) was
also included in the second protocol. During this time, the animals were kept under normal cyclical lighting conditions. ERGs
were recorded on the third day of treatment, 2 h after the final
injection. After the last recording, the squirrels were sacrificed
by decapitation after deep anesthesia with isofluorane. Their
eyes were enucleated, and after removal of the cornea, lens, and
vitreous and partial removal of the retina, the RPE was collected
for RPE65 activity assays.
ERG data were analyzed in MATLAB (MathWorks) with custom scripts and colormaps designed and made publicly available
by Matteo Niccoli (Niccoli, 2018). Three to five trials per flash
intensity were averaged after baseline subtraction. The averaged traces were used to identify the amplitude of the a-wave
as the maximal downward deflection in the first 30 ms after
stimulation and the amplitude of the b-wave as the maximal
upward deflection up to 100 ms after stimulation. To assess the
effect of pharmacological treatment, the difference before and
10 min after the bleaching protocol (expressed as a percentage)
was calculated for both the a- and b-wave amplitudes at every
light intensity used for stimulation. This difference was calculated only for flash intensities >10 cd·s/m2. Below this intensity,
ERG responses were small and noisy. Recovery data spanning
the full 600-s time window were fit with the exponential rise to
plateau equation
	F(t) = a + c × [1 − exp (− t / τ)]
using the lsqcurvefit routines in MATLAB, with a (baseline shift
variable), c (fractional recovery at t = +∞), and τ (the recovery
time constant) variables treated as free parameters. Although
cone sensitivity recovery obeys a rate-limited kinetic model
(Mahroo and Lamb, 2004), reasonable fits were obtained here
with the simpler exponential function. The recovery fraction
was calculated as the b-wave amplitude 500–600 s after bleach
divided by the prebleach b-wave amplitude.
Quantification of MB-001 in squirrel and mouse eyes
Eyes from ground squirrels or C57BL6/J mice that had received
three consecutive days of IP MB-001 treatment (8 mg/kg/day)
were homogenized in 3 ml of 10 mM sodium phosphate buffer,
pH 7.4, containing 50% vol/vol methanol and hydroxylamine
(50 mM). After adding 4 ml brine, the resulting mixture was
extracted twice with 4 ml ethyl acetate. The combined extracts
were dried in vacuo and reconstituted in 400 µl ethanol containing 2 nmol emixustat as the internal standard. This solution
(100 µl) was analyzed by liquid chromatography–electrospray
ionization tandem mass spectrometry with a Finnigan LXQ mass
spectrometer (Thermo Fisher Scientific) and a 4.6 × 150–mm
ZORBAX Eclipse XDB-C18 column (Agilent) with a gradient of
acetonitrile in water (0–100% in 20 min) as the eluent at a flow
rate of 0.5 ml/min. Amounts of MB-001 were quantified based
on a standard curve representing the relationship between the
amount of MB-001 and the ratio of the corresponding selected
Kiser et al.
Effects of retinoid cycle inhibition on cone vision

reaction monitoring peak areas of MB-001 (m/z 304.2→257.2) to
emixustat (m/z 264.2→246.2).
Online supplemental material
Fig. S1 shows validation of the DES1 activity assay. Fig. S2 shows
the effects of RPE65 inhibitors on DES1 enzymatic function. Fig.
S3 shows the effects of MB-001 on dark-adapted mouse ERG
responses. Fig. S4 shows the impact of MB-001 treatment on ERG
responses in ground squirrels after the multiday dosing schedule used in wild-type mice. Fig. S5 shows the standard curve
for MB-001 quantification. Fig. S6 shows the quantification of
MB-001 levels in mouse and squirrel eyes. Table S1 summarizes
the kinetic data presented in Fig. S2.

Results

Emixustat derivatives selectively inhibit RPE65 over DES1
Although the inhibitory activity of emixustat toward RPE65 has
been studied extensively, its selectivity for this enzyme has not
been established. Specifically, it is unknown whether emixustat
or its derivatives also inhibit DES1. We therefore determined the
influence of these RPE65 inhibitors on DES1 catalytic function
(Fig. 2 A). We observed that MB-001 and emixustat had little or
no inhibitory activity toward DES1, even at a concentration of
100 µM (Fig. 2 B), whereas RPE65 activity was drastically reduced
by these compounds at a concentration of 10 µM (Fig. 2 C); the
latter finding is consistent with prior data (Kiser et al., 2015;
Zhang et al., 2015b). Conversely, the known DES1 inhibitor fenretinide (Rahmaniyan et al., 2011) strongly suppressed DES1
dihydroceramide desaturase activity at a concentration of 10 µM
(Fig. 2 B) but had minimal effects on RPE65 retinoid isomerase
activity (Fig. 2 C), confirming previous results (Golczak et al.,
2008). Inhibition by Ret-NH2 was intermediate between these
two extremes, with ∼50% inhibition of DES1 activity achieved at
a concentration of 100 µM and slightly less RPE65 inhibition at
a concentration of 10 µM compared with the emixustat derivatives. The Ki values and modes of inhibition of the RPE65 inhibitors toward DES1 activity are summarized in Fig. S2 and Table
S1. These data establish the utility of emixustat derivatives in
selectively blocking RPE65-driven retinoid isomerization.
Impact of retinoid isomerase inhibition on cone dark
adaptation after a brief step bleach
Having established the selectivity of Ret-NH2, emixustat, and
MB-001 toward RPE65, we next used ERG to investigate how
their inhibition of the classical RPE visual cycle affects cone
photoreceptor function. To facilitate isolation of the cone component of the ERG response, these experiments were performed
with mice lacking the α subunit of rod transducin (Gnat1−/−),
an essential component of the rod phototransduction cascade.
Deletion of the transducin α subunit blocks rod responses while
preserving the structure of the retina as well as cone signaling
(Calvert et al., 2000).
First, we recorded cone b-wave responses from dark-adapted
Gnat1−/− mice by in vivo ERGs and estimated their photopic
b-wave flash sensitivity. Treatment of mice with Ret-NH2 had no
detrimental effect on the function of cones under dark-adapted
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Figure 2. Selectivity of RPE65 and DES1 inhibitors. (A) Chemical structures of RPE65 and DES1 inhibitors used in this study. (B) Inhibitory effects of retinoids, emixustat, and emixustat derivatives on DES1 activity in liver microsomes from 8-wk-old Lrat−/− mice. Fenretinide, a known DES1 inhibitor, at a concentration of 10 µM suppressed DES1 activity nearly as well as heat treatment or omission of the required NADH cofactor. RPE65 inhibitors, in contrast, had less
pronounced effects on activity. Assays shown here were performed at a fixed substrate concentration of 0.5 µM. Activity levels are normalized to that of the
DMSO-only control samples. DMSO, at the concentration used in these assays (0.2% vol/vol), did not affect DES1 activity. (C) Inhibitory effects of retinoids,
emixustat, and emixustat derivatives on 11-cis-retinol production in RPE microsomes. Compounds at final concentrations of 10 µM or 100 µM were incubated
with RPE microsomes and 20 µM all-trans-retinol. Activities are normalized to DMSO-only treated samples. The bar graphs show mean values, and error bars
represent SDs from at least three separate experiments.

conditions, as their sensitivity was not suppressed compared
with that of DMSO-treated controls (Fig. 3 A). Mice then were
exposed to brief bright light to bleach >90% of their visual pigment. This resulted in a substantial initial desensitization, followed by progressive recovery as the cone visual pigments were
gradually regenerated. Comparison of the time course of conedriven b-wave sensitivity recovery revealed that treatment with
Ret-NH2 suppressed the late phase of cone dark adaptation relative to vehicle-treated controls. As a result, the final level of cone
sensitivity 1 h after the bleach was twofold lower in Ret-NH2–
treated mice than in control mice treated with DMSO (Fig. 3 A).
This result is consistent with the view that, in mice, the late phase
of cone dark adaptation after a brief step bleach is mediated by
the classical RPE visual cycle. In contrast, the early phase of cone
dark adaptation over the first ∼10 min after the bleach was not
suppressed by treatment with Ret-NH2. Using data from salamander cones (Kefalov et al., 2005), the recovery of cone sensitivity
at this time point suggests that >50% of the cone visual pigment
was regenerated despite inhibition of the RPE visual cycle. This
finding suggests that after a step bleach, the early component of
mouse cone dark adaptation is independent of RPE65 (i.e., not
acutely dependent on continuous RPE65 activity).
The initial component of cone dark adaptation in vivo is
thought to be driven by the intraretinal visual cycle (Kolesnikov
et al., 2011). To confirm that this part of cone recovery is independent of the RPE, we examined the dark adaptation of cones in isolated retina after a step bleach. Under these conditions, the RPE is
removed and the RPE visual cycle does not contribute to recovery,
leaving the intraretinal visual cycle as the sole source of chromophore driving cone pigment regeneration. Comparison of retinas
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from vehicle- and Ret-NH2–treated mice revealed identical time
courses of cone dark adaptation (Fig. 3 B). Thus, Ret-NH2 did
not affect cone dark adaptation in the isolated retina, consistent
with our finding that Ret-NH2 does not effectively inhibit DES1.
Rather, these findings indicate that the early rapid phase of cone
dark adaptation after a step bleach is independent of RPE65 and
is instead driven by the intraretinal visual cycle. Using the same
ex vivo system, we also investigated the impact of DES1 inhibition by fenretinide on cone dark adaptation. Compared with
vehicle-treated retinas, those exposed to 100 µM fenretinide
exhibited a modest decrease in photosensitivity (Fig. 4). Photosensitivity was further decreased only slightly at a concentration
of 650 µM, indicating that the effect had plateaued. These results
further support a physiological role for DES1 in cone recovery
mediated by the intraretinal visual cycle.
Emixustat and MB-001 exhibited even greater inhibitory
potency and selectivity toward RPE65 compared with Ret-NH2
(Fig. 2). Like Ret-NH2, both emixustat (Fig. 5 A) and MB-001
(Fig. 5 B) inhibited the late phase of cone dark adaptation, but
neither compound slowed early recovery after the photobleach.
Ret-NH2, emixustat, and MB-001 contain primary amine functional groups that are capable of directly reacting with retinaldehyde to form Schiff base adducts. To rule out the possibility
of retinaldehyde sequestration giving rise to the late-phase
dark adaptation effects, we tested QEA-B-001-NH2, a compound
that functions as a retinaldehyde sequestrant without inhibiting RPE65 (Zhang et al., 2015a). No suppression of cone dark
adaptation in mice treated with QEA-B-001-NH2 was observed
(Fig. 5 C). These observations demonstrate that the early component of mouse cone dark adaptation in the intact eye after a
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Figure 3. Effect of Ret-NH2 on mouse cone dark adaptation. (A and B)
Cone b-wave ERG responses were recorded in vivo (A), and cone a-wave ERG
responses were recorded ex vivo (B). Sensitivity in each case was estimated as
the ratio of the dim flash response and the corresponding flash intensity and
further normalized to the maximal ERG response amplitude. Rod transducin
α-deficient mice (Gnat1−/−) were used to isolate the cone-specific component
of the light responses. Mice (3 mo old) were dark adapted overnight, injected
with 50 µl DMSO or Ret-NH2 dissolved in DMSO to 5 µg/µl, and then kept in
darkness for 22–26 h. After determining the sensitivity in the dark-adapted
state, we exposed the eyes or isolated retinas for 30 s to bright 520-nm light
estimated to bleach >90% of their visual pigment. Episodic dim flash stimulation was then used to follow the recovery of cone b-wave sensitivity in vivo
(A) in mice treated with DMSO (n = 16) or with Ret-NH2 (n = 10). Ret-NH2 did
not affect the early phase of cone dark adaptation driven by the intraretinal
visual cycle but blocked its late phase, driven by the RPE visual cycle. Recovery of cone a-wave sensitivity ex vivo (B) was measured in isolated retinas
from mice treated with DMSO (n = 7) or with Ret-NH2 (n = 6). Ret-NH2 did
not affect the dark adaptation of cones in isolated retina. Data are presented
as means ± SEM.

brief step bleach is driven by an RPE65-independent mechanism, whereas RPE65 contributes substantially to the late-phase
recovery process.
Impact of RPE65 inhibition on cone function during extended
photopic conditions
In their normal daily function, cones are rarely exposed to such
brief, intense light exposures as the ones used in the preceding
experiments. Thus, to test the efficiency of chromophore supply
to cones under more physiological conditions, we exposed mice
to 30 min of bright background light followed by a period of dark
adaptation. Inefficient pigment regeneration in this case should
result in gradual depletion of cone visual pigment and progressive cone desensitization during light exposure (Kolesnikov et
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al., 2015), as well as a delay in the subsequent cone dark adaptation upon extinction of the background light. In DMSO-treated
Gnat1−/− mice, this protocol resulted in an ∼100-fold cone desensitization caused by light adaptation in bright background
(Fig. 6 A, black circles). However, cone sensitivity remained stable for the duration of the background light, indicating sustained
pigment regeneration. Upon the return to darkness, cone sensitivity recovered gradually over the next 30 min as cone pigment
regenerated. Notably, treatment with emixustat did not compromise the ability of cones to maintain their sensitivity during the
30-min exposure to bright light (Fig. 6 A). Thus, cones were able
to sustain robust function in bright light despite blockade of the
RPE visual cycle by emixustat. All phases of cone dark adaptation
upon return to darkness were delayed in emixustat-treated mice
compared with vehicle-treated controls, suggesting an important role of the RPE visual cycle for cone pigment regeneration
in these conditions. Similar experiments with MB-001 yielded
comparable results; however, we observed a subtle and gradual
desensitization of the cones during the 30 min of photopic exposure (Fig. 6 B). Finally, we also tested how cone function under
photopic conditions is affected by the all-trans-retinaldehyde
sequestrant QEA-B-001-NH2. Consistent with the inability of
this compound to inhibit cone dark adaptation after a step bleach
(Fig. 5 C), QEA-B-001-NH2 also had no effect on cone function
during prolonged light exposure (Fig. 6 C). The subsequent dark
adaptation of cones also was comparable in QEA-B-001-NH2– and
DMSO-treated mice.
Effects of retinoid isomerase inhibitor treatment on wild-type
mouse photoreceptor responses
As a prelude to the evaluation of multiday RPE65 inhibitor
treatment on cone function in the cone-dominant ground squirrel, we tested RPE65 inhibitor treatment on ERG responses in
wild-type C57BL/6J mice. For these studies, we used MB-001
because of its strongly selective inhibitory activity toward RPE65
(Fig. 2 and Table S1).
We recorded a series of dark-adapted (Fig. 7) and lightadapted (Fig. 8) ERGs from mice treated with vehicle and then
exposed to a bleach, or from mice treated with MB-001 with or
without a bleach exposure. In vehicle-treated mice, the darkadapted ERG was composed of two major components: a negative
polarity a-wave followed by a positive polarity b-wave (Fig. 7 A).
The a-wave reflects the light-induced closure of ion channels
along the rod outer segments, and the b-wave reflects the mass
response of depolarizing bipolar cells (Abd-El-Barr et al., 2009).
Rod recovery after a strong photobleach is an established surrogate for the ability of RPE65 to synthesize 11-cis-retinol, as the
rate of rhodopsin regeneration after a full bleach is dependent
on the expression level and activity of RPE65 (Wenzel et al., 2001;
Lyubarsky et al., 2005). Compared with ERG responses obtained
from vehicle-treated mice, which were comparable to prebleach
responses, the ERG a- and b-wave amplitudes were markedly
reduced in mice given MB-001 and subjected to a photobleach
(Fig. 7, A–C). Although clear signals were seen in these animals,
the responses were reduced in amplitude, and their waveforms
closely resembled those obtained in Gnat1−/− mice, which lack
rod-mediated function (Calvert et al., 2000; Wu et al., 2004). The
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Figure 4. Effect of fenretinide on cone dark adaptation in isolated retina. (A–E) Representative families of ex vivo cone ERG responses from Gnat1−/−
mouse retinas under specified conditions. (A and C) Test flashes of 505-nm light with intensities of 235, 705, 2.4 × 103, 7.0 × 103, 1.7 × 104, 5.7 × 104, 2.0 × 105,
and 6.0 × 105 photons/µm2 were delivered at time 0. (B, D, and E) Test flashes of 505-nm light with intensities of 2.4 × 103, 7.0 × 103, 1.7 × 104, 5.7 × 104, 2.0
× 105, 6.0 × 105, 2.0 × 106, and 5.7 × 106 photons/µm2 were delivered at time 0. In all panels, responses to 1.7 × 104 photons/µm2 light are shown in red for
comparison of cone sensitivity recovery after a bleach. (F) Averaged cone intensity–response functions (mean ± SEM) for dark-adapted conditions treated for
1 h with 1.3% DMSO (vehicle control, open circles; n = 6) or with 650 µM fenretinide (open red circles; n = 6) and 1 h after a bleach of retinas preincubated for
1 h in 1.3% DMSO (vehicle control, closed black circles; n = 11), 100 µM fenretinide (closed blue squares; n = 6), or 650 µM fenretinide (closed red circles; n =
9). The recovery of cone sensitivity was suppressed by treatment with fenretinide at both 100 µM and 650 µM.

overall amplitudes of the dark-adapted ERG responses of mice
administered MB-001 but not exposed to the bleach were intermediate between vehicle- and MB-001–treated mice that underwent the bleach, with rod contributions to the waveforms clearly
evident (Fig. 7, A–C). These results indicate that administration
of MB-001 to mice maintained under standard vivarium lighting
was sufficient to impact rod-mediated function, likely because
of the accumulation of apo-opsin (Lyubarsky et al., 2004) and
Kiser et al.
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consequent constitutive signaling that desensitizes the phototransduction pathway in these cells (Cornwall and Fain, 1994;
Jäger et al., 1996). To exclude the potential effects of MB-001 on
the ERG that are unrelated to visual cycle suppression, we administered MB-001 or vehicle to fully dark-adapted mice for two consecutive days and 2 h after the last dose measured scotopic ERG
responses. As shown in Fig. S3, we observed comparable scotopic
ERG responses between MB-001– and vehicle-treated mice under
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Figure 5. Effect of RPE65 inhibitors on mouse cone dark adaptation in
vivo. The recovery of cone b-wave flash sensitivity after a 90% bleach was
compared between Gnat1−/− mice treated with DMSO (n = 16) and mice
treated with RPE65 inhibitors. (A–C) The late, RPE visual cycle–driven phase
of cone dark adaptation was suppressed by emixustat (A; n = 14) and by
MB-001 (B; n = 14), but not by QEA-B-001-NH2 (C; n = 10). The early, retina
visual cycle–driven phase of cone dark adaptation was unaffected in all three
cases. Data are presented as means ± SEM.

these conditions, consistent with the lack of prebleach ERG
effects observed in Gnat1−/− mice (Figs. 5 B and 6 B). After this initial ERG recording, mice were subjected to a strong photobleach
(10 min × 10,000 lux) and then allowed to dark adapt for 22 h.
After dark adaptation, we repeated the scotopic ERG measurements. Whereas vehicle-treated mice had postbleach responses
comparable to the prebleach values, those from MB-001–treated
mice were drastically reduced (Fig. S3). After a 2-wk drug washout period, the responses of the MB-001–treated mice returned
to baseline, demonstrating a lack of long-term residual effects
Kiser et al.
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Figure 6. Effect of RPE65 inhibitors on mouse cone function in vivo
during and after prolonged exposure to background light. Cone b-wave
sensitivity was monitored during a 30-min exposure of 3-mo-old Gnat1−/−
mice to bright 300-cd/m2 white background light (gray bars) and then for 35
min in darkness. (A) Compared with control DMSO treatment (n = 6), cones
from mice treated with emixustat (n = 10) were equally desensitized by the
background light but had largely suppressed subsequent dark adaptation.
(B) In contrast, in mice treated with MB-001 (n = 8), cones gradually desensitized during background adaptation and had suppressed subsequent dark
adaptation. (C) Treatment with QEA-B-001-NH2 (n = 6) had no effect on the
function of cones in background light or during the subsequent dark adaptation. Data are presented as means ± SEM.

caused by either the drug treatment or light exposure. These data
confirm that ERG effects arising from MB-001 treatment are a
result of visual cycle suppression rather than off-target effects
and that this suppression is fully reversible.
Under light-adapted conditions, the mouse ERG response has
a major positive b-wave that is preceded by a small negative wave
(Fig. 8 A). The positive b-wave reflects cone-depolarizing bipolar
cell activity, whereas the negative wave primarily reflects postreceptor activity of the inner retina (Sharma et al., 2005; Shirato
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Figure 7. Impact of MB-001 and fenretinide administration on wild-type mouse scotopic ERG responses. (A) Representative dark-adapted ERGs obtained
from 7-mo-old C57BL/6J mice treated with vehicle and bleached, treated with MB-001 and bleached, or treated with MB-001 and not bleached. Animals were
dark adapted for 6 h before ERG recordings. Flash strength is color coded: black, −3.6 log cd·s/m2; blue, −2.4 log cd·s/m2; light purple, −1.2 log cd·s/m2; purple,
0 log cd·s/m2; red, 1.4 log cd·s/m2. (B and C) Dark-adapted a-wave and b-wave responses for the three treatment groups. Note that MB-001 reduced a- and
b-wave ERG amplitude recovery both after a bleach and, to a lesser extent, in mice reared under standard vivarium lighting conditions. Data points indicate
means (±SEM) of five mice per group for the vehicle and bleached, MB-001–treated groups and three mice for the nonbleached, MB-001–treated group.
(D) Representative dark-adapted ERGs obtained from 2-mo-old C57BL/6J mice administered vehicle and bleached or administered fenretinide and bleached.
Animals were dark adapted for 6 h before ERG recordings. Flash strength is color coded: black, −3.6 log cd·s/m2; blue, −2.4 log cd·s/m2; light purple, −1.2 log
cd·s/m2; purple, 0 log cd·s/m2; red, 1.4 log cd·s/m2. (E and F) Scotopic a-wave and b-wave responses for the two treatment groups. Data points indicate means
(±SEM) of three mice per group. Fenretinide treatment reduced scotopic b-wave amplitudes slightly, whereas a-wave responses were unaffected.

et al., 2008). Light-adapted ERGs of mice administered MB-001
were reduced in both bleached and nonbleached animals in comparison to those treated with vehicle (Fig. 8, A and B). This suppression was most prominent with midintensity flashes where
the ERG response was reduced approximately fivefold and
threefold in bleached and nonbleached animals, respectively,
and gradually equalized with higher flash stimuli. These results
indicate that RPE65 plays a role in restoring cone photoreceptor
activity in wild-type mice during dark adaptation after a bleach,
as well as during exposure to standard vivarium light levels, consistent with the results obtained from Gnat1−/− mice.
We also investigated the impact of multiday treatment with
the DES1 inhibitor fenretinide on ERG responses in wild-type
mice. We administered fenretinide for three consecutive days at
a dose of 267 mg/kg/day, which is equivalent to a high-dose regimen previously evaluated for ocular effects in humans (Marmor
et al., 2008). On the third day, 1 h after the final injection, we
subjected the mice to a 10-min × 10,000-lux photobleach and
then allowed them to dark adapt for 6 h before ERG recordings
Kiser et al.
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were performed. Based on human clinical data, fenretinide can
exert profound effects on rod function with little impact on cones
(Marmor et al., 2008). In wild-type C57BL6/J mice, we found that
scotopic ERGs were mildly reduced (Fig. 7, D–F), whereas photopic responses were slightly elevated relative to vehicle control
(Fig. 8, C and D). Thus, high-dose fenretinide does not appear to
negatively impact the steady-state level of cone pigment regeneration to a detectable degree under these conditions.
Effects of multiday RPE65 inhibitor treatment on ground
squirrel cone ERG responses
Many of the biochemical studies on the intraretinal visual cycle
have been conducted using retinas from cone-dominant species
(Mata et al., 2002, 2005; Gollapalli and Rando, 2003; Muniz et
al., 2009). However, the contribution of the classical visual cycle
to cone function has not been thoroughly evaluated in these animals. We tested the effect of RPE65 inhibition on cone-driven
ERG responses in the ground squirrel, a rodent whose photoreceptor population consists almost exclusively of cones (Jacobs
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Figure 8. Impact of MB-001 and fenretinide administration on wild-type mouse cone-driven ERG responses. (A) Representative light-adapted ERGs
obtained from 7-mo-old C57BL/6J mice administered vehicle and bleached, administered MB-001 and bleached, or administered MB-001 and not bleached.
These photopic ERGs were recorded immediately after the scotopic recordings shown in Fig. 7 (A–C) and a 5-min light adaptation period under steady 30 cd/m2
background light, which was maintained during the recordings. Flash strength is color coded: blue, 0 log cd·s/m2; purple, 0.9 log cd·s/m2; red, 1.9 log cd·s/m2.
(B) Photopic b-wave responses for the three treatment groups. Data points indicate means (±SEM) of five mice per group for the vehicle and MB-001 bleach
groups and three mice for the MB-001 no-bleach group. Note that MB-001 reduced cone ERG amplitude recovery after a bleach and reduced cone ERG amplitude
to a lesser extent in mice reared under standard vivarium lighting conditions. (C) Representative light-adapted ERGs obtained from 2-mo-old C57BL/6J mice
administered vehicle and bleached or administered fenretinide and bleached. These photopic ERGs were recorded immediately after the scotopic recordings
shown in Fig. 7 (D–F) and a 5-min light adaptation period under steady 30 cd/m2 background light, which was maintained during the recordings. Flash strength
is color coded: black, −0.8 log cd·s/m2; blue, 0 log cd·s/m2; purple, 0.9 log cd·s/m2; red, 1.9 log cd·s/m2. (D) Photopic b-wave responses for the two treatment
groups. Data points indicate the means (±SEM) of three mice per group. Note that light-adapted ERG b-wave amplitudes were slightly greater in mice treated
with fenretinide as compared with those treated with vehicle.

and Yolton, 1969; Mustafi et al., 2016). MB-001 or vehicle was
administered to these animals for three consecutive days. After
pupillary dilation, MB-001– or vehicle-treated squirrels were
uniocularly exposed to bright light for 10 min, which completely
suppressed cone responses to a midintensity flash, followed by
ERG recordings from both eyes. After a 6-wk washout period, the
treatment and control groups were crossed over and the experiment was repeated. Using this treatment regimen, which caused
pronounced ERG effects in mice as described above, the a- and
b-wave ERG amplitudes were essentially unaffected by MB-001
treatment in the ground squirrels (Fig. S4). Unlike mice, ground
squirrels do not produce a reliable rod ERG response that could
be used to definitively assess the degree of RPE65 inhibition by
MB-001 (Jacobs et al., 1980). Although MB-001 was detected in
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the eyes of ground squirrels (Figs. S5 and S6), given the relatively
long period of time that elapsed between the final treatment dose
and the ERG recordings (∼1 d), we considered the possibility that
MB-001 is more rapidly eliminated in ground squirrels than in
mice and hence lost its efficacy during this period.
To address this possibility, we repeated the experiment but
administered the final treatment dose 2 h before ERG recordings. We used the original 8 mg/kg dose as well as an 80 mg/kg
dose to help ensure that an adequate concentration of MB-001
was present in the RPE at the time of ERG recording. To directly
measure the degree of RPE65 inhibition in these animals, the
RPE was collected from squirrel eyes after ERG recordings, and
RPE65 activity was measured from the cell lysates. As shown
in Fig. 9, 11-cis-retinol was generated in assays using RPE from
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Figure 9. Impact of MB-001 treatment on the production of 11-cis-retinol by ground squirrel RPE. (A–D) Examples of high-performance liquid chromatography separation of retinoids obtained from vehicle-treated squirrels (A), squirrels treated with MB-001 at doses of 8 mg/kg/day (B) or 80 mg/kg/day (C), and
untreated bovine RPE (D). Blue and red traces show separations from assays performed only with added vehicle (dimethylformamide) or with all-trans-retinol
delivered in dimethylformamide, respectively. Retinoids are labeled as follows: 1, all-trans-retinyl esters; 2, 11-cis-retinol; 3, all-trans-retinol; and 4, 13-cis-retinol. The insets in A and B show absorbance spectra for peaks 2 and 3. (E) Quantification of 11-cis-retinol production by the indicated RPE samples. The different
vehicle and 8 mg/kg MB-001 samples are biological replicates. Each sample was assayed in duplicate. The results are presented as means, and the error bars
represent SDs. An RPE65 immunoblot of the samples loaded at the same relative amounts as used in the assay demonstrates that the difference in isomerase
activity between the vehicle and drug-treated samples is not attributable to large differences in RPE65 levels. Only a single band at ∼65 kD corresponding to
RPE65 was visualized on the immunoblot; hence, the image was cropped to the area surrounding this band. DMF, dimethylformamide.

vehicle-treated animals (Fig. 9 A), and the production was augmented by the addition of all-trans-retinol to the assay mixture,
as observed for bovine RPE (Fig. 9 D). In contrast, RPE samples
obtained from squirrels treated with either dose of MB-001 failed
to generate 11-cis-retinol (Fig. 9, B and C). Immunoblots showed
a comparable amount of RPE65 in each sample, thus ruling out
a lack of visual cycle enzymes in the MB-001–treated samples
underlying the absence of activity (Fig. 9 E). Whereas vehicle
and 8 mg/kg/day MB-001 treatment were well tolerated by the
animals, significant (>50%) mortality was observed for animals
treated with the 80 mg/kg/day dose of MB-001.
We applied two different ERG recording paradigms to these
animals. First, we subjected the animals to a 10-min photobleach
that completely suppressed ERG responses and then monitored
for ERG recovery with midintensity test flashes over the ensuing
10 min. Second, after the 10-min recovery period, we subjected
animals to a series of light flashes to assess ERG responses over
a range of flash stimuli. Compared with the vehicle treatment,
MB-001 at both doses dramatically prolonged the time to recovery in all animals investigated (Fig. 10 and Table 1). The mean
time constant for recovery was ∼51 s before treatments and 40 s
after 3 d of vehicle treatment but was slowed to ∼1,500 s and
∼294 s in the low and high MB-001 treatment groups. Moreover,
in two of the four animals treated with MB-001, the fractional
recovery 10 min after the end of the photobleach was substantially less than the pretreatment value, whereas vehicle-treated
Kiser et al.
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animals on average matched their pretreatment recovery levels
(Fig. 10). Despite this marked delay in ERG response recovery,
animals from all treatment groups had only subtle alterations
in their ability to respond to subsequent strobe flashes (Fig. 11).
Compared with pretreatment responses (Fig. 11 A), the effects
of MB-001 treatment at a dose of 8 mg/kg/day were essentially
indistinguishable from vehicle alone (Fig. 11, B and C). MB-001 at
80 mg/kg produced varying responses in the two animals treated
with this regimen (Fig. 11 D). In one animal, ERG responses were
comparable to those of vehicle treatment. The other animal
had a much more pronounced response to the drug treatment,
with marked effects on pre- and postbleach a-wave and b-wave
responses. We note that this animal died 3 d after the recordings
were made. It is likely that the more profound effect observed in
this animal was a result of toxicity rather than an accentuated
on-target effect of the drug.
We also tested the effects of fenretinide on the squirrel cone
ERG response. We administered fenretinide at a dose of 166 mg/
kg, the body surface area–adjusted equivalent dose used in mice,
daily for three consecutive days and then assessed ERG responses
using the same experimental protocol described in the preceding
paragraph. We found that fenretinide treatment slowed the time
constant of recovery about threefold relative to vehicle (Fig. 10
and Table 1) but did not impact responsiveness to a subsequently
delivered strobe flash series (Fig. 11 E). We observed a trend
toward the extent of recovery being augmented by fenretinide
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Table 1. Rate constants and recoveries derived from curve fitting to the data shown in Fig. 10
Vehicle

MB001 (8 mg/kg)

MB001 (80 mg/kg)

Fenretinide

Recovery time
constant

Recovery
fraction

Recovery time
constant

Recovery
fraction

Recovery time
constant

Recovery
fraction

Recovery time
constant

Recovery
fraction

Day 1 Day 3

Day 1

Day 1 Day 3

Day 1

Day 1

Day 3

Day 1

Day 1 Day 3

Day 1

Day 3

s

Day 3

s

Day 3

s

Day 3

s

35.6

44.0

0.7450 0.6400

52.8

2067.7

0.7480 0.4130

47.0

404.6

0.9710 0.5380

44.2

188.9

0.7540 0.9240

32.8

28.0

0.9620 0.7600

32.8

933.1

0.6910 0.6860

14.4

183.5

0.7550 0.6010

107.1 220.4

0.5850 0.6630

77.6

48.2

0.7450 0.8420

48.3

0.9490 1.2230

0.72

30.70

294.05

0.86

48.67 40.07

0.82

0.75

42.80 1500.40

0.55

0.57

150.9

66.53 186.73

0.76

0.94

Recovery fraction indicates the degree of recovery 10 min after the end of the photobleaching period. For each treatment, the individual rows represent
values calculated from individual animals. The final row shows column averages.

treatment relative to vehicle control (Fig. 10 and Table 1), which
is consistent with our findings in wild-type mice (Fig. 8, C and D).
Collectively, the experiments in ground squirrels indicate
that RPE65 is involved in mammalian cone pigment regeneration as deduced from sensitivity recovery measurements after
an extended photobleach, but the cones can clearly function in
a relatively normal fashion with RPE65 activity acutely blocked
by pharmacological means. The same conclusion can be drawn
for the putative inhibition of DES1 activity by fenretinide,

although the effects of this compound were milder compared
with MB-001.

Discussion

The electrophysiological experiments described in this study
reveal differing effects of three RPE65-selective inhibitors
(Ret-NH2, emixustat, and MB-001) on cone pigment regeneration and cone photoreceptor dark adaptation.

Figure 10. Recovery of ERG b-wave responses after a photobleach in drug- and vehicle-treated ground squirrels. After baseline ERG recordings, the
animals were subjected to a 10-min photobleach that completely suppressed b-wave responses. They were subsequently monitored for ERG recovery with
flashes giving approximately half-maximal responses (100 cd·s/m2, except for the animal whose responses are shown in the lower graph of the 80 mg/kg/day
MB-001 column, which required 300 cd·s/m2 to elicit midsaturating responses). Data shown as blue circles were obtained at day 1 before drug or vehicle treatment. Data shown as red circles were obtained after three consecutive days of vehicle or drug treatment at the indicated dose. The later ERGs were measured
∼2 h after the final dose of drug. Each panel shows data from a single animal. MB-001 at either dose greatly delays the recovery of cone sensitivity. Fenretinide
also delayed, to a smaller degree, cone sensitivity recovery in two of the three treated animals.
Kiser et al.
Effects of retinoid cycle inhibition on cone vision

Journal of General Physiology
https://doi.org/10.1085/jgp.201711815

584

Kiser et al.
Effects of retinoid cycle inhibition on cone vision

Journal of General Physiology
https://doi.org/10.1085/jgp.201711815

585

After brief, intense light exposure, the initial fast recovery
of cone light sensitivity, which reflects intraretinal visual cycle
function (Kolesnikov et al., 2011), is largely unaffected in Gnat1−/−
mice treated with RPE65-selective inhibitors, whereas the second
phase recovery component that completes dark adaptation and is
attributable to the classical visual cycle (Kolesnikov et al., 2015)
is markedly slowed (Fig. 3 A and Fig. 5, A and B). These observations are consistent with the existence of a rapid RPE65-independent mechanism of visual chromophore delivery to cone
photoreceptors.
The cones of mice treated with RPE65 inhibitors also displayed sustained light responsiveness during prolonged exposure to moderately intense background illumination, again
suggesting RPE65-independent chromophore regeneration
(Fig. 6, A and B). Interestingly, the time required for cone photoreceptor resensitization after the 30-min light exposure
(Fig. 6) was somewhat slower compared with the situation in
which bleaching was achieved with a single intense light flash
(Fig. 5), possibly reflecting a depletion of cis-retinoid sources.
Resensitization was slowed to a much greater degree in mice
treated with RPE65 inhibitors, indicating that RPE65 may be
particularly important in supporting cone function during sustained light exposure.
Consistent with this proposal, cone ERG responses were also
suppressed in wild-type mice after extended administration of
MB-001 and a photobleach followed by a dark adaptation period,
as indicated by the reduced photopic b-wave amplitudes in these
animals compared with vehicle-treated controls (Fig. 8, A and
B). We also observed mild suppression of cones and, to a greater
degree, rod responses without a prior photobleach when the
mice were reared in normal vivarium light. This likely reflects
bleaching desensitization caused by the inability of the photoreceptor pigments to regenerate after being bleached by the
vivarium light.
In the cone-dominant ground squirrel, as in Gnat1−/− mice,
the time required for flash sensitivity recovery after an extended
bleach was markedly prolonged in MB-001–treated animals, and
in some cases the extent of sensitivity recovery was also suppressed (Fig. 10 and Table 1). However, after the recovery period,
the ground squirrel cone ERG responses to a flash series were
remarkably well preserved (Fig. 11), indicating the presence of
robust pigment regeneration mechanism(s) that are not reliant
on continuous RPE65 activity. In both wild-type mice and ground
squirrels, we conclusively ruled out residual RPE65 activity as

being responsible for the cone-mediated responses. In the case of
mice, this was confirmed by the absence of rod-related ERG signals after a 6-h postbleach dark adaptation (Fig. 7, A–C). In squirrels, RPE65 activity in isolated RPE was abolished by MB-001
treatment (Fig. 9).
Our finding that cone function is preserved in the setting of
reduced RPE-based visual cycle function is consistent with data
obtained from human clinical trials of emixustat treatment.
Subjects receiving both acute (Kubota et al., 2012) and chronic
(Kubota et al., 2014) dosing regimens had minimal changes in
cone ERG flash and flicker responses despite substantial suppression of rod responses because of RPE65 blockade. Although
overall cone electrical activity was preserved, dyschromatopsia
was a frequently reported side effect associated with emixustat
treatment, which has been attributed to perturbations in rod cell
modulation of cone sensory output (Kubota et al., 2012).
Fenretinide also exerted modulatory effects on ERG
responses in these animal models. In isolated Gnat1−/− mouse
retinas, fenretinide reduced the extent of cone sensitivity
recovery (Fig. 4), although not as much as observed after the
complete block of the intraretinal visual cycle by ablation of the
Müller cells (Wang and Kefalov, 2009). We also observed a lag in
ground squirrel cone sensitivity recovery after a bleach in animals treated with this drug (Fig. 10 and Table 1). These effects
of fenretinide appear to be dependent on the time allowed for
dark recovery, as fenretinide-treated wild-type mice that were
allowed an extended time for dark adaptation (6 h) had fully
recovered and perhaps even had elevated cone ERG responses
(Fig. 8, C and D). We also observed slightly elevated responses
after bleach recovery in ground squirrels (Fig. 10 and Table 1).
The reduction of cone sensitivity exerted by fenretinide may
relate to its ability to inhibit the putative Müller cell retinoid
isomerase DES1 (Kaylor et al., 2013). Although fenretinide
exhibits selectivity for DES1 over RPE65 (Fig. 2, B and C), it has
other documented molecular targets, including LRAT (Dew
et al., 1993), β-carotene dioxygenase 1 (Poliakov et al., 2012a),
and retinol-binding protein 4 (Berni and Formelli, 1992), all
of which are known to contribute directly or indirectly to
visual cycle function. Moreover, retinoic acid, a metabolite of
fenretinide, can inhibit retinol dehydrogenase enzymes (Law
and Rando, 1989), potentially including those relevant to the
cone-specific visual cycle (Sato and Kefalov, 2016). Therefore,
we cannot rule out that the ERG alterations are caused by fenretinide’s effects on enzymes other than DES1. The relatively

Figure 11. Impact of MB-001 and fenretinide treatment on ground squirrel ERG responses to a range of flash intensities. (A) Ground squirrel ERG
responses to a flash series were measured on day 1 before any drug or vehicle treatment both before and after a 10-min photobleach. (B–E) The responses
were measured again in the same fashion 3 d later after daily administration of vehicle, MB-001 at 8 mg/kg/day, MB-001 at 80 mg/kg/day, and fenretinide
at 166 mg/kg/day. The final dose of drug was administered ∼2 h before the ERG recordings. The left graphs show ERG traces for each type of treatment. The
arrows indicate the time of flash onset. The middle panels show a-wave responses to each flash, and the right panels show the corresponding graphs for b-wave
responses. The luminance-response plots of A show averaged data for all animals studied (n = 10). The luminance-response plots for B–E show the posttreatment responses for the individual animals studied (red and orange circles for pre- and posttreatment responses, respectively) along with the averaged day 1
responses (mean shown as a dashed line with the SDs shown as shaded error bars). Vehicle-treated group, n = 3; 8 mg/kg MB-001–treated group, n = 2; 80
mg/kg MB-001–treated group, n = 2; fenretinide-treated group, n = 3. Apart from a single animal in the high-dose MB-001 group (D), the pre- and postbleach
responses in drug- and vehicle-treated animals were highly similar to the day 1 pretreatment responses. The greater responses in the single animal may have
been caused by off-target drug toxicity.
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subtle effects of fenretinide on cone function are in line with
clinical data showing that this compound has little impact on
human cone function, even at high doses (Kaiser-Kupfer et al.,
1986; Marmor et al., 2008).
Collectively, these data demonstrate that cones rely on both
continuous RPE65 activity and an independent second source of
11-cis-retinaldehyde for regeneration of their visual pigments.
The reduced ERG recovery rate that we observe in mice treated
with RPE65 inhibitors when cone bleaching is achieved with a
prolonged light exposure rather than a short step of light suggests
a critical role for stored forms of 11-cis-retinoids in cone pigment
regeneration. Indeed, the involvement of cellular 11-cis-retinaldehyde–binding protein (CRALBP) in cone pigment regeneration
has received considerable experimental support (Saari et al.,
2001; Collery et al., 2008; Fleisch et al., 2008; Xue et al., 2015).
CRALBP is expressed in the RPE and Müller glia (Bunt-Milam and
Saari, 1983), where it noncovalently binds 11-cis-retinaldehyde
as well as 11-cis-retinol with low nanomolar affinity (Saari et al.,
1982; Saari and Bredberg, 1987; Crabb et al., 1998). These cis-retinoids can be released for rapid visual pigment regeneration
(Saari and Crabb, 2005). In CRALBP knockout (Rlbp1−/−) mice,
rod dark adaptation after illumination is delayed >10-fold (Saari
et al., 2001). Rlbp1−/− mice also exhibit defects in M-opsin cellular distribution and consequently display M-cone dysfunction
because of cis-retinoid deficiency, including greatly suppressed
M-cone sensitivity and dark adaptation. These abnormalities can
be rescued by selective reexpression of CRALBP in Müller glia
(Xue et al., 2015).
The contribution of CRALBP toward intraretinal cone regeneration can be estimated. The quantity of this protein in the
bovine neurosensory retina is ∼1 nmol/eye, and its molar ratio
to rhodopsin is 1:20 (Stubbs et al., 1979). Assuming that (a) this
ratio is similar in the mouse retina, (b) the amount of cone opsin
in mouse retina is ∼1% of rhodopsin (Daniele et al., 2011), and (c)
CRALBP and 11-cis-retinoids form a 1:1 complex (Saari et al., 1982;
He et al., 2009), we can estimate that there are on the order of
five CRALBP-associated 11-cis-retinoids per cone pigment stored
in Müller cells.
Adding to this source of potential chromophore for the regeneration of cone pigments are 11-cis-retinyl esters found in variable amounts in the RPE and neurosensory retina, depending on
the species (Bridges et al., 1987; Rodriguez and Tsin, 1989; Das et
al., 1992; Kaylor et al., 2013; Palczewska et al., 2014; Babino et al.,
2015; Mustafi et al., 2016). Ground squirrels in particular possess large quantities of 11-cis-retinyl esters in their neural retina
(Mata et al., 2002), and this may account for the highly resilient
responsiveness of their cones.
The availability of these stored forms of readily mobilized
11-cis-retinoids, together with the ability of cones to operate
over a wide dynamic range and with high degrees of baseline
bleaching (Malchow and Yazulla, 1986; Jones et al., 1993), could
explain the ability of these cells to maintain function in sustained
bright light. Two important outstanding issues are the origin of
11-cis-retinoids stored in the neural retina (i.e., derived from the
classical vs. intraretinal visual cycle) and the necessity for ongoing cis-retinoid production by the putative intraretinal visual
cycle for cone-mediated vision.
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Figure S1. Schematic and validation of the DES1 activity assay. (A) DES1 dihydroceramide desaturase activity relies on NADH to provide electrons
needed for production of an electrophilic, activated oxygen species that abstracts hydrogen from the substrate. The assay system uses a 3H-4,5–labeled
synthetic dihydroceramide as a substrate. DES1 activity specifically releases tritium from the substrate as water, which is separated from unreacted substrate and measured to quantify enzymatic activity. (B) Assessment of the linear range of the DES1 activity assay. Reactions were performed at 37°C for 0, 5,
10, and 20 min in the presence of 30, 60, and 120 mg Lrat−/− mouse liver microsomes at a fixed substrate concentration of 0.5 µM. Under these conditions,
the assay was relatively linear with respect to both time and enzyme concentration. (C) Steady-state kinetics of mouse liver DES1 activity toward C8-dihydroceramide. Assays were performed as described in the Materials and methods section with increasing concentrations of unlabeled C8-dihydroceramide
and a fixed quantity of 4,5-3H-C8-dihydroceramide. Vmax and Km values of 10.7 ± 0.3 nmol/min/g and 0.50 ± 0.07 µM, respectively, were determined for this
assay system based on a total number of 28 data points measured in three separate experiments spanning a range of C8-dihydroceramide concentrations
from 0.011 to 10.4 µM.

Figure S2. Effects of RPE65 inhibitors on DES1 enzymatic function. DES1 dihydroceramide desaturase assays were performed according to the standard
method in the presence of the indicated compounds at substrate concentrations below, at, and above the Km value for C8-dihydroceramide. The steady-state
kinetic constants and the best fit mode of reversible inhibition derived from global curve fitting along with the estimated Ki values are shown in Table S1.
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Figure S3. Effects of MB-001 on dark-adapted mouse ERG responses. (A and B) ERG responses to a 1.65 log cd·s/m2 strobe flash recorded from mice
(C57BL/6J, 2 mo old) that received IP DMSO vehicle or 8 mg/kg MB-001 immediately before, 22 h after, and 2 wk after a strong photobleach (10 min × 10,000
lux). (C and D) Plots of the scotopic a-wave amplitudes for the two groups of mice. (E and F) Scotopic b-wave amplitudes for the two groups of mice. DMSO
group, n = 4; MB-001 group, n = 3. The data are shown as means ± SEM.
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Figure S4. Impact of MB-001 treatment on ERG responses in ground squirrels after the multiday dosing schedule used in wild-type mice. (A and B)
ERG responses from a single representative ground squirrel after vehicle (A) or MB-001 (B) treatment showing minimal effects of MB-001 treatment on cone
function. ERG recordings were made in light-adapted 6-mo-old squirrels after 3 d of vehicle or MB-001 treatment before (left) and 10 min after (right) bleaching (see Materials and methods) using a brief flash of variable intensity as stimulation (black arrows, three to five trials per flash intensity). During the 3 d of
treatment, animals were housed in normal cyclical lighting conditions. (C and D) Treatment group averages of ERG responses, which do not reveal systematic
differences between vehicle- and MB-001–treated animals. We obtained mean a-wave and b-wave amplitudes at each light intensity after normalization by
the a-wave amplitude to the 4,000 cd·s/m2 flash before bleaching. We excluded responses to flash intensities <10 cd·s/m2 (shaded regions) because they
were small and corrupted by noise. (E and F) Changes in ERG responses induced by bleaching are not significantly different between treatment groups using
this original treatment schedule. We obtained mean a-wave and b-wave amplitude differences (prebleach response − postbleach response; n = 4 squirrels;
error bars represent SEM) that show no significant differences at any light intensity between treatments. We compared these ratios as paired measurements
(vehicle vs. MB-001) with Wilcoxon rank–sum tests using 5% as the significance level.

Kiser et al.
Effects of retinoid cycle inhibition on cone vision

Journal of General Physiology
https://doi.org/10.1085/jgp.201711815

S23

Figure S5. Standard curve for MB-001 quantification. 2 nmol emixustat was spiked into a serial solution of MB-001 (0–2.4 nmol) in ethanol. 100 μl of the
resulting solutions was injected into a liquid chromatography/mass spectrometry system. (A and B) The peak areas of emixustat chromatograms, recorded
by selective reaction monitoring at m/z 264.2→246.2 (A) and MB-001 at m/z 304.2→257.2 (B), were recorded. (C) A standard curve depicting the ratio of the
corresponding peak areas of MB-001 to emixustat and the ratio of their known amounts used in the experiment.
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Figure S6. Quantification of MB-001 levels in mouse and squirrel eyes. Eye extracts were dissolved in ethanol containing 2 nmol emixustat. 100 μl of
the solution was injected into the liquid chromatography/mass spectrometry system. (A–D) The chromatogram obtained by selective reaction monitoring at
m/z 304.2→257.2 demonstrated that the eyes of C57BL/6J mice (A) and ground squirrels (B) treated with MB-001 both contained substantial amounts of the
compound, although the peaks of MB-001 in the eyes from the animals treated with DMSO were negligible (C and D). The amounts of MB-001 in both animals
were calculated based on the standard curve shown in Fig. S5.

Table S1. Steady-state kinetic constants obtained for DES1-mediated dihydroceramide desaturase activity in the presence of RPE65 inhibitors
Concentration

Emixustat

MB-001

Ret-NH2

μM

Vmax

Km

Vmax

Km

Vmax

Km

400

4.4

0.35

6.1

0.21

4.9

6.1

200

6.8

0.47

10.5

0.37

10.4

2.7

100

7.5

0.37

11.9

0.39

13.9

1.4

50

8.4

0.38

10.6

0.33

8.6

0.40

0

9.6

0.37

8.3

0.30

10.3

0.47

Mode of inhibition

Noncompetitive; Ki = 360 µM

Noninhibitory

Partial mixed or uncompetitive; Ki =
∼80 µM

Vmax and Km values were derived by curve fitting as shown in Fig. S2. The bottom row shows the best fit mode of inhibition and associated Ki values derived
from global analysis of the data. The activity simulation and minor inhibition of DES1 activity at higher concentrations precluded global fit analysis for
MB-001.
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